MoneyWorks4Me

Shilpa Medicare ties up with Cadila Healthcare

24 Sep 2021 Evaluate

Shilpa Medicare, via its wholly owned subsidiary, Shilpa Biologicals (SBPL), has entered into a definitive agreement with Cadila Healthcare (CHL) for production-supply of the ZyCov-D vaccine drug substance from its integrated Biologics R&D cum Manufacturing center at Dharwad, Karnataka.

The targeted production of the ZyCoV-D vaccine from this facility will be mutually agreed upon by both parties.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

811.00 -10.90 (-1.33%)
17-Aug-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.70
Dr. Reddys Labs. 1195.15
Cipla 1432.35
Lupin 2225.00
Zydus Lifesciences 1144.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: